The two gigantic projects launched on either ends of Hyderabad–the Pharma City project at Mucherla village in Ranga Reddy district, spread across 19,000 acres and the Medical Devices Park located at Sultanpur village of Sangareddy district–are giving the much needed push for growth of highly advanced industrial clusters located on the outskirts of Hyderabad.
As per the data available from the Telangana State Industrial Infrastructure Development Corporation (TSIIDC), as many as 19 companies have already signed up and are in the process of setting up shops in the Telangana Medical Devices Park.
According to industry experts, the Medical Devices Park at Sultanpur is likely to become Asia’s largest diagnostic and healthcare equipment manufacturing hubs of India. Recently, a stent manufacturing facility was also set up by Sahajanand Medical Technologies with an investment of Rs.250 crore giving the much needed push for the industrial investment in the state.
The government’s upcoming Pharma City project also aims to create the world’s largest integrated ecosystem in a 19,000-acre space, which will cater to create a complete value chain for the pharmaceutical industry. “Of late Hyderabad has emerged as the most potential hubs for the industrial growth in the country. Particularly the ecosystem for life sciences in Genome Valley has helped the Indian Immunologicals Limited (IIL) to grow in the metro area of Hyderabad. The planned Pharma City and Medical Devices Park will further strengthen Hyderabad’s leadership in life sciences at global level. We have established units manufacturing vaccines for human health and for animal health. During the current decade, IIL established a state-of-the-art vaccine manufacturing unit at Karakapatla, in Genome Valley,” observed Dr Prasanna Deshpande, deputy managing director, IIL.
After the formation of Telangana, there was a situation of ambiguity among the investors, whether they stay in Hyderabad or shift their base to Andhra Pradesh and other areas. However, post 2014, things have come out clearly and an amicable and most friendly industrial investment environment has emerged with proactive initiatives by the state government. Some of the important pharma industries which have invested in Telangana include Ferring Pharma (Switzerland), Chemo (Spain), Jamp Pharma (Canada) and others which have given the much needed impetus for the consolidation of the investment sentiment in the state. “It is really a proud moment to share that Hyderabad has made a global mark in the attraction of new investment. Hyderabad has been able to create a remarkable mark globally in life sciences and healthcare segments,” said Jayesh Ranjan, principal secretary (Industries, Commerce, and ITEC), government of Telangana.
The Principal secretary is expecting that in the next 10 years ahead, Telangana state will double its investment opportunities to more than 100 billion dollars and provide jobs to 4 lakh people in various parts of the state. – Pharma Biz